ArticleFrontiers in microbiology2026
A risk-gate mechanistic-ecological framework for assessing emergence potential of henipa-related viruses.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Henipa-related viruses can cause severe disease following rare zoonotic introductions, yet spillover alone does not determine the likelihood of outbreak emergence. Here we propose a risk-gate mechanistic-ecological framework to assess emergence potential across henipa-related viruses. Using the well-characterized henipaviruses Nipah and Hendra together with the more recently described Langya and Mojiang viruses as comparative examples, we define a sequential pathway linking upstream exposure (Step 0) to host entry and tissue access (Gate 1), within-host replication and immune antagonism (Gate 2), and transmission amplification (Gate 3). By tagging the strength of available evidence and identifying gate-specific knowledge gaps, the framework distinguishes biological constraints from operational uncertainties including diagnostics, infection prevention and control (IPC), and response capacity. This evidence-tagged framework provides a practical One Health roadmap for comparing established and emerging henipa-related viral threats. We present it as a conceptual, review-oriented tool rather than a validated predictive model and outline how future retrospective outbreak analyses could test its utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.